iSpecimen annual r&d spending
2020
2021
2022
2023
2024
2025
iSpecimen R&D Spending Growth & History (ISPC)
iSpecimen's r&d spending was $2.2M for fiscal 2025.
View full iSpecimen company overviewiSpecimen annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.2M | $666,505 | +44.63% |
| 2024 | 2024-12-31 | $1.5M | −$125,523 | −7.75% |
| 2023 | 2023-12-31 | $1.6M | $145,313 | +9.86% |
| 2022 | 2022-12-31 | $1.5M | $594,277 | +67.59% |
| 2021 | 2021-12-31 | $879,243 | $560,008 | +175.42% |
| 2020 | 2020-12-31 | $319,235 | — | — |
iSpecimen quarterly r&d spending
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $290,230 | −$246,081 | −45.88% |
| Q1 2026 | 2026-03-31 | $247,549 | −$297,818 | −54.61% |
| Q4 2025 | 2025-12-31 | $527,033 | — | — |
| Q3 2025 | 2025-09-30 | $551,104 | — | — |
| Q2 2025 | 2025-06-30 | $536,311 | — | — |
| Q1 2025 | 2025-03-31 | $545,367 | — | — |
iSpecimen r&d spending trends
Over the last five fiscal years, iSpecimen's r&d spending increased from $319,235 to $2.2M, a change of $1.8M. The latest reported quarter, Q2 2026, shows $290,230.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review iSpecimen source filings ↗